Literature DB >> 8601628

Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model.

D M Shih1, L Gu, S Hama, Y R Xia, M Navab, A M Fogelman, A J Lusis.   

Abstract

In an effort to identify genetic factors contributing to atherogenesis, we have studied inbred strains of mice that are susceptible (C57BL/6J) and resistant (C3H/HeJ) to diet-induced aortic fatty streak lesions. When maintained on a low-fat diet, HDL isolated from both strain C57BL/6J (B6) and C3H/HeJ (C3H) mice protect against LDL oxidation in a coculture model of the artery wall. However, when maintained on an atherogenic diet high in fat and cholesterol, the HDL isolated from B6 mice lose the capacity to protect, whereas HDL from C3H mice protect equally well. Associated with the loss in the ability of HDL to protect is a decrease in the activity of serum paraoxonase, a serum esterase carried on HDL that has previously been shown to protect against LDL oxidation in vitro. The levels of paraoxonase mRNA decreased in B6 mice upon challenge with the atherogenic diet but increased in C3H, indicating that paraoxonase production is under genetic control. In a set of recombinant inbred strains derived from the B6 and C3H parental strains, low paraoxonase mRNA levels segregated with aortic lesion development, supporting a role for paraoxonase in atherogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8601628      PMCID: PMC507227          DOI: 10.1172/JCI118589

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.

Authors:  A D Watson; J A Berliner; S Y Hama; B N La Du; K F Faull; A M Fogelman; M Navab
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

3.  Linkage mapping of 40 randomly isolated liver cDNA clones in the mouse.

Authors:  C H Warden; M Mehrabian; K Y He; M Y Yoon; A Diep; Y R Xia; P Z Wen; K L Svenson; R S Sparkes; A J Lusis
Journal:  Genomics       Date:  1993-11       Impact factor: 5.736

4.  Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations.

Authors:  M C Blatter Garin; C Abbott; S Messmer; M Mackness; P Durrington; D Pometta; R W James
Journal:  Biochem J       Date:  1994-12-01       Impact factor: 3.857

Review 5.  Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.

Authors:  J A Berliner; M Navab; A M Fogelman; J S Frank; L L Demer; P A Edwards; A D Watson; A J Lusis
Journal:  Circulation       Date:  1995-05-01       Impact factor: 29.690

6.  Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

Authors:  M I Mackness; S Arrol; C Abbott; P N Durrington
Journal:  Atherosclerosis       Date:  1993-12       Impact factor: 5.162

7.  LPS-induced release of IL-1 beta, IL-6, IL-8, TNF-alpha and sCD14 in whole blood and PBMC from persons with high or low levels of HDL-lipoprotein.

Authors:  J B Eggesbø; I Hjermann; P K Lund; G B Joø; R Ovstebø; P Kierulf
Journal:  Cytokine       Date:  1994-09       Impact factor: 3.861

8.  Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.

Authors:  A D Watson; M Navab; S Y Hama; A Sevanian; S M Prescott; D M Stafforini; T M McIntyre; B N Du; A M Fogelman; J A Berliner
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

9.  A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate.

Authors:  R A Hegele; J H Brunt; P W Connelly
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-01       Impact factor: 8.311

10.  Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS.

Authors:  M M Wurfel; S T Kunitake; H Lichenstein; J P Kane; S D Wright
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  31 in total

Review 1.  Genetics of atherosclerosis: the search for genes acting at the level of the vessel wall.

Authors:  V Villa-Colinayo; W Shi; J Araujo; A J Lusis
Journal:  Curr Atheroscler Rep       Date:  2000-09       Impact factor: 5.113

2.  Gene expression analysis of mouse chromosome substitution strains.

Authors:  Keith R Shockley; Gary A Churchill
Journal:  Mamm Genome       Date:  2006-06-12       Impact factor: 2.957

Review 3.  The paraoxonase gene family and atherosclerosis.

Authors:  David Seo; Pascal Goldschmidt-Clermont
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

Review 4.  CYP/PON genetic variations as determinant of organophosphate pesticides toxicity.

Authors:  Gurpreet Kaur; A K Jain; Sandeep Singh
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

5.  The effect of age on the paraoxonase and arylesterase activity of pregnant mothers and their infants.

Authors:  Mahmut Abuhandan; Alpay Cakmak; Abdullah Taskın; Emrah Karakaya; Abdurrahim Kocyigit; Hatip Kılıc
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

6.  Differential effect of lysophospholipids on activities of human plasma paraoxonase1, either soluble or lipid-bound.

Authors:  Cheon Ho Park; Su Duy Nguyen; Mee Ree Kim; Tae-Sook Jeong; Dai-Eun Sok
Journal:  Lipids       Date:  2006-04       Impact factor: 1.880

7.  Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.

Authors:  M Navab; S Hama-Levy; B J Van Lenten; G C Fonarow; C J Cardinez; L W Castellani; M L Brennan; A J Lusis; A M Fogelman; B N La Du
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

Review 8.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

9.  Serum paraoxonase 1 activity is decreased in thyroid dysfunction.

Authors:  F Azizi; F Raiszadeh; M Solati; A Etemadi; M Rahmani; M Arabi
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

10.  A common haplotype within the PON1 promoter region is associated with sporadic ALS.

Authors:  John E Landers; Lijia Shi; Ting-Jan Cho; Jonathan D Glass; Christopher E Shaw; P Nigel Leigh; Frank Diekstra; Meraida Polak; Ildefonso Rodriguez-Leyva; Stephan Niemann; Bryan J Traynor; Diane McKenna-Yasek; Peter C Sapp; Ammar Al-Chalabi; Anne-Marie A Wills; Robert H Brown
Journal:  Amyotroph Lateral Scler       Date:  2008-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.